RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.56-57
Main Authors: Kelly, K.M., Daw, S., Mauz‐Körholz, C., Mascarin, M., Michel, G., Cooper, S., Beishuizen, A., Leger, K.J., Garaventa, A., Buffardi, S., Brugières, L., Harker‐Murray, P., Cole, P.D., Drachtman, R.A., Manley, T., Francis, S., Sacchi, M., Leblanc, T.
Format: Article
Language:English
Subjects:
Hodgkin's lymphoma
Immunotherapy
Lymphoma
Monoclonal antibodies
Subgroups
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.26_2629